News & Updates
Next Generation Sequencing statement
A statement from the MMS regarding Next-Generation Sequencing technology, in response to the Hayes Group review. Read the statement here.
The Mitochondrial Medicine Society is pleased to offer a live Google map of the Mitochondrial Global Networks. Click here or go to the Toolkit tab to see more.
The MMS North American Consensus Criteria for the Diagnosis and Treatment of Mitochondrial Disease are now available in the journal Genetics in Medicine. Click here to see more.
Program Chair, Fernando Scaglia
MMS Board Members, Mary Kay Koenig, Amel Karaa, Mark Korson along with Past-Presidents
Fellowship in Mitochondrial Medicine
The North American Mitochondrial Disease Consortium (NAMDC) fellowship is soliciting applications. Read more here
2013-2014 MMS Project
MMS members are asked to join the NINDS effort to create Common Data Elements (CDEs) for Mitochondrial Disease. This effort is being led by Petra Kaufman. Please contact MMS officer Dr. Amy Goldstein for more information.
A committee has formed to create Consensus Criteria for Mitochondrial Disease Evaluations. We hope to provide a comprehensive set of guidelines to the clinician community by 2014.
Joint Statement regarding the potential risks of carnitine treatment
In anticipation of concerns and possible confusion from media coverage of a recent article about possible atherogenic effects of trimethylamine oxide which could arise from carnitine administration, we post this statement in conjunction with other agencies. Read the statement at this link.